Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study

被引：0

作者：

Francisco, Gerard ^{[1
,2
]}

Feng, Wayne ^{[3
]}

Munin, Michael ^{[4
]}

Ngo, Kenneth ^{[5
]}

Schwartz, Marc ^{[6
]}

Sadeghi, Marjan ^{[7
]}

Zuzek, Aleksej ^{[7
]}

Esquenazi, Alberto ^{[8
]}

机构：

[1] Univ Texas Houston, McGovern Med Sch, Houston, TX USA

[2] TIRR Mem Hermann, Houston, TX USA

[3] Duke Univ, Sch Med, Durham, NC 27706 USA

[4] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA

[5] Brooks Rehabil Hosp, Jacksonville, FL USA

[6] MS Biostat LLC, Jacksonville, FL USA

[7] AbbVie Allergan, Dublin, Ireland

[8] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA USA

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203112

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P12-8.012

引用

页数：4

共 50 条

[31] Real-world treatment utilization and effectiveness of onabotulinumtoxinA in multiple sclerosis patients treated for spasticity from the ASPIRE study
Bandari, D. S.
Mayadev, A.
Sakel, M.
Esquenazi, A.
Zuzek, A.
Largent, J.
Francisco, G. E.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 321 - 322
[32] Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: A pooled analysis
Munin, M.
Camoes-Barbosa, A.
Cordero-Garcia, C.
Althaus, M.
Comes, G.
Vacchelli, M.
Walter, C.
Wissel, J.
MOVEMENT DISORDERS, 2024, 39 : S703 - S704
[33] Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: A pooled analysis
Munin, M.
Camoes-Barbosa, A.
Cordero-Garcia, C.
Althaus, M.
Comes, G.
Vacchelli, M.
Walter, C.
Wissel, J.
MOVEMENT DISORDERS, 2024, 39 : S703 - S704
[34] Consistent Dose Over Time and Within Treatment Interval Groups With OnabotulinumtoxinA: Analysis From the Adult Spasticity International Registry (ASPIRE)
Esquenazi, Alberto
Feng, Wuwei
Wittenberg, George F.
Gallien, Philippe
Baricich, Alessio
Fanning, Kristina
Zuzek, Aleksej
Francisco, Gerard E.
Bandari, Daniel S.
NEUROLOGY, 2021, 96 (15)
[35] CLASSIFICATION OF UPPER LIMB SPASTICITY PATTERNS IN PATIENTS WITH MULTIPLE SCLEROSIS: A PILOT OBSERVATIONAL STUDY
Filippetti, Mirko
Lugoboni, Linde
Di Censo, Rita
Degli Esposti, Luca
Facciorusso, Salvatore
Varalta, Valentina
Santamato, Andrea
Calabrese, Massimiliano
Smania, Nicola
Picelli, Alessandro
JOURNAL OF REHABILITATION MEDICINE, 2024, 56
[36] Time to retreatment with botulinum toxin A in upper limb spasticity management: Initial data from the Upper Limb International Spasticity (ULIS)-III Study
Turner-Stokes, L.
Ashford, S.
Jacinto, J.
Fheodoroff, K.
Suarez, G.
Maisonobe, P.
MOVEMENT DISORDERS, 2017, 32
[37] MANAGEMENT OF UPPER LIMB SPASTICITY WITH BOTULINUM TOXIN A: BASELINE DATA FROM THE ITALIAN COHORT OF THE UPPER LIMB INTERNATIONAL SPASTICITY (ULIS)-III STUDY
Millevolte, Marzia
Cosma, Michela
Manca, Mario
Molteni, Franco
Diverio, Manuela
Girlanda, Paolo
Ianeri, Giancarlo
Maisonobe, Pascal
Caglioni, Patrizia Maria
Caltagirone, Carlo
TOXICON, 2018, 156 : S80 - S81
[38] ONABOTULINUMTOXINA TREATMENT UTILIZATION VARIES BY ETIOLOGY OF SPASTICITY, WHILE MAINTAINING HIGH PATIENT CLINICIAN SATISFACTION: RESULTS FROM THE ASPIRE STUDY
Francisco, Gerard E.
Bandari, Daniel S.
Bavikatte, Ganesh
Jost, Wolfgang H.
Largent, Joan
Zuzek, Aleksej
Esquenazi, Alberto
TOXICON, 2018, 156 : S35 - S36
[39] OnabotulinumtoxinA treatment for spasticity reduces disability outcomes in treatment-naive patients and reduces caregiver burden: results from the ASPIRE study
Fredericks, M.
Jost, W. H.
Ellenbogen, A. L.
Wittenberg, G. F.
Ngo, K.
Largent, J.
Zuzek, A.
Francisco, G. E.
Esquenazi, A.
INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 54 - 54
[40] High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Francisco, Gerard E.
Bandari, Daniel S.
Bavikatte, Ganesh
Jost, Wolfgang H.
Mccusker, Emily
Largent, Joan
Zuzek, Aleksej
Esquenazi, Alberto
TOXICON-X, 2020, 7

← 1 2 3 4 5 →